Causes · Diagnosis · Treatment · Emerging Therapies
A cough that has lasted more than 8 weeks in adults (or more than 4 weeks in children) is considered chronic. While a healthy person may cough up to 15 times a day as a normal reflex, people with chronic cough can experience nearly 800 coughs per day.
Chronic cough affects between 2.5% and 18% of the population worldwide and is one of the most common reasons people visit their doctor. It is particularly common in women in their 50s and 60s.
In many people, chronic cough is not just a symptom of another disease — it becomes a disease in its own right, caused by an overactive, hypersensitive cough reflex.
| Type | Adults | Children | Common Causes |
|---|---|---|---|
| Acute Cough | Less than 3 weeks | Less than 2 weeks | Viral infections, acute bronchitis, environmental exposures |
| Subacute Cough | 3–8 weeks | 2–4 weeks | Post-infectious cough, pertussis (whooping cough) |
| Chronic Cough | More than 8 weeks | More than 4 weeks | Asthma, reflux, nasal drip, or unexplained hypersensitivity |
Urinary incontinence · Rib fractures · Fainting (syncope) · Exhaustion · Disrupted sleep · Headaches and dizziness
Social isolation and embarrassment · Anxiety and depression · Difficulty at work or in public · Reduced quality of life and wellbeing
The cough reflex is controlled by nerves that run from your airways to your brain. In chronic cough, these nerves become hypersensitized — meaning they fire too easily and too often, even when there is no real threat to clear. This is called Cough Hypersensitivity Syndrome (CHS).
Think of it like a home alarm that has become so sensitive it goes off when a door closes. The alarm (cough reflex) is working too hard, even without a real danger (infection or irritant).
In adults with a normal chest X-ray, the vast majority of chronic coughs are due to one (or more) of these three conditions:
Mucus or inflammation from your nose or sinuses drips down the back of your throat and irritates the nerves that trigger coughing. You may notice a constant need to clear your throat, or a "tickle" at the back of your throat.
Often linked to: Allergic rhinitis (hay fever) · Non-allergic rhinitis · Chronic sinusitis
Asthma doesn't always cause wheezing. In some people, cough is the only symptom. There are several asthma-related causes of cough:
Acid from your stomach can travel up the food pipe (oesophagus) and trigger coughing in two ways: by stimulating shared nerve pathways between the oesophagus and lungs, or by tiny droplets of acid reaching the airways directly. In some people, cough is the ONLY sign of reflux — with no heartburn at all ("silent reflux").
Key lifestyle changes: Elevate the head of your bed · Avoid fatty foods, coffee, alcohol, and chocolate · Eat smaller meals · Do not lie down for 2–3 hours after eating · Lose excess weight if applicable
Blood pressure medicines called ACE inhibitors (e.g., lisinopril, ramipril, enalapril) cause a dry, hacking cough in up to 1 in 5 patients. This happens because the drug allows a substance called bradykinin to build up in the airways, sensitizing the cough reflex. If you take an ACE inhibitor and have a persistent dry cough, speak to your doctor about switching to an alternative — the cough usually resolves within 4 weeks of stopping.
Tell your doctor immediately if your cough is accompanied by any of these symptoms:
Diagnosis follows a structured, step-by-step process, starting with the most common causes and progressing to specialized tests if needed.
Your doctor will take a full medical history, review your medications, and perform a physical exam. A Chest X-ray (CXR) is always the first test ordered.
Treatment is most effective when targeted at the underlying cause. Many patients have more than one contributing factor, requiring a combined approach.
Lifestyle changes are essential and must be combined with medication for best results:
| Lifestyle Change | Why It Helps |
|---|---|
| Elevate the head of the bed | Uses gravity to prevent nocturnal acid reflux into the oesophagus |
| Avoid fat, chocolate, caffeine, alcohol | Maintains lower oesophageal sphincter tone |
| Weight loss | Reduces intra-abdominal pressure and physical drive for reflux |
| Avoid lying down after meals (2–3 hours) | Minimises reflux risk |
If your cough continues despite thorough investigation and treatment of all identified causes, it may be labelled Refractory Chronic Cough (RCC) or Unexplained Chronic Cough (UCC). This is not a failure of diagnosis — it reflects that the cough reflex itself has become a neuropathic (nerve-driven) condition, similar to chronic pain. Treatment then focuses on calming the overactive nerves.
Speech-language pathology has emerged as one of the most effective non-drug treatments for refractory cough. The goal is to give you voluntary control over your cough reflex. Studies show that over 80% of patients experience significant improvement after just 1–4 sessions.
Techniques like relaxed throat breathing, the cough suppression swallow, and pursed-lip breathing to interrupt the cough urge
Stay well hydrated · Avoid caffeine and smoking · Breathe through your nose to warm and humidify incoming air
Understanding the "vicious cycle" of coughing and identifying your personal triggers helps break the pattern
A structured programme combining exercise, breathing retraining, airway clearance techniques, and psychosocial support. Benefits include:
We are in an exciting era for cough research, with several new drugs targeting the root molecular causes of chronic cough currently in late-stage clinical trials.
The first P2X3 antagonist to complete Phase 3 trials, showing a 15–18% reduction in cough frequency compared to placebo. It is approved in Europe, UK, Japan, and Switzerland but was not approved in the USA due to concerns about side effects — specifically a taste disturbance (dysgeusia) affecting up to 65% of patients at higher doses.
An oral dual opioid receptor agent. In the Phase 2a RIVER trial, showed a 56% reduction in cough frequency. Also being studied for cough in Idiopathic Pulmonary Fibrosis (IPF) in the CORAL trial.
Block the effects of substance P, a key sensory neurotransmitter in the airways. Early trials showed promise in improving cough-related quality of life.
Target nerve channels sensitive to heat, acid, and mechanical stress in the airways. Research continues into more potent molecules after mixed early trial results.
Being studied for their ability to modulate central cough pathways — particularly promising for patients with interstitial lung disease (ILD).
| Drug | Selectivity | Status (2025) | Efficacy | Taste Side Effect |
|---|---|---|---|---|
| Gefapixant | P2X3 / P2X2/3 | Approved EU/Japan; Rejected USA | 15–18% reduction | High (>60%) |
| Camlipixant | Highly selective P2X3 | Phase 3 (CALM-1/2) | 34% reduction | Low (<7%) |
| Sivopixant | Selective P2X3 | Discontinued | Insufficient efficacy | N/A |
| Eliapixant | Selective P2X3 | Discontinued | — | Liver concerns |
PBB is one of the most common causes of chronic wet cough in children under 6. It is a persistent bacterial infection of the lower airways that does not cause the typical symptoms of pneumonia.
| Type | Characteristics | Management |
|---|---|---|
| Post-Infectious Cough | Follows a viral cold; gradually resolves on its own | Observation; avoid over-treatment |
| Asthmatic Cough | Dry cough, often at night or with exercise | Trial of inhaled corticosteroids for 2–4 weeks |
| Somatic (Habit) Cough | Loud "honking" sound; disappears completely during sleep | Reassurance, suggestion therapy, speech therapy |
| Upper Airway Cough Syndrome | Associated with nasal congestion and allergy signs | Saline drops, intranasal steroids, antihistamines |
| Protracted Bacterial Bronchitis | Wet, moist cough lasting >4 weeks, under age 6 | 2–4 week course of oral antibiotics |
Medical history, physical exam, and chest X-ray. Review of all medications (especially ACE inhibitors). Referral to pulmonologist, ENT, allergist, or gastroenterologist as needed.
Sequential or combined treatment of the most likely cause(s). Each treatment requires adequate time to work — a minimum of 4–8 weeks. Keep a symptom and trigger diary.
FeNO testing, spirometry, CT imaging, 24-hour pH monitoring, or laryngoscopy if initial treatments have failed.
If cough persists, referral for speech-language therapy, consideration of neuromodulators (gabapentin, low-dose morphine), and pulmonary rehabilitation. Discussion of upcoming clinical trials.
Cough is a dynamic condition. Triggers may change with seasons, stress levels, and health. Continued partnership with your healthcare team is key.
Chronic cough itself is not typically life-threatening, but it can be a symptom of serious underlying conditions (see red flags, Section 4). Once serious causes are ruled out, the focus is on managing quality of life and symptom control.
Nighttime coughing is commonly caused by postnasal drip pooling at the back of the throat when lying flat, or by acid reflux rising up the oesophagus without gravity to hold it back. Elevating your head and treating reflux or rhinitis often helps significantly.
Yes. Stress and anxiety can lower the threshold for the cough reflex and reduce the effectiveness of the descending nerve pathways that normally suppress unnecessary coughing. Addressing mental health is a legitimate and important part of chronic cough management.
Not necessarily. Refractory and unexplained chronic cough is a recognized medical diagnosis. It reflects a neuropathic (nerve-driven) condition — like chronic pain — rather than an untreated serious disease. With the right specialist team and the new treatments arriving in 2025–2026, there is genuine hope for improvement.
Phase 3 trial results for camlipixant are expected in late 2025. If successful, regulatory submission for approval in the EU, UK, and USA could follow in 2026. Ask your specialist about clinical trial eligibility in the meantime.
A methodical, stepwise approach is necessary. Most cases are eventually explained and treatable — but it may take several months.
Many patients have more than one contributing factor. Treating all of them together gives the best results.
Speech-language therapy is highly effective — over 80% of patients improve. Ask for a referral.
New drugs targeting the P2X3 receptor and other pathways are expected to transform treatment for refractory cough in the next 1–2 years.